Get the Stockscreener App
10.18
2.10%
0.185
Bridgebio Oncology Therapeutics Inc stock is traded at $10.18, with a volume of 33,857.
It is up +2.10% in the last 24 hours and up +0.00% over the past month.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
See More
Previous Close:
$9.99
Open:
$10.01
24h Volume:
33,857
Relative Volume:
20.48
Market Cap:
$685.16M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.70
$10.25
1-Week Range:
$9.50
$10.25
52-Week Range:
$9.50
$10.25
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Company Profile
Name
Bridgebio Oncology Therapeutics Inc
Sector
Industry
Phone
857 702 0377
Address
C/O CORMORANT ASSET MANAGEMENT, LP, BOSTON
Compare BBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBOT
Bridgebio Oncology Therapeutics Inc
|
10.20 | 685.16M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.235 | 1.88B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.38 | 703.96M | 0 | 16.92M | -1.35M | 0.29 |
|
AAM
Aa Mission Acquisition Corp
|
10.47 | 460.41M | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
10.12 | 526.75M | 0 | 0 | 0 | 0.00 |
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Financials Data
There is no financial data for Bridgebio Oncology Therapeutics Inc (BBOT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):